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den, the annual incidence of arthroscopic surgery of the meniscus is
approximately 250 per 100 000, and the incidence of MRI-diagnosed
anterior cruciate ligament tears is at least 80 per 100 000 in the ages
between 10 and 64. In addition to these incidence data, other evidence
from epidemiological studies on unselected populations suggest a high
prevalence of these types of lesions even in the absence of a history of
a known trauma to the knee. At some 10−20 years after the diagnosis,
some 50% of those diagnosed with an ACL or meniscus tear have OA with
associated pain and functional impairment: the young patient with an old
knee. These individuals make up a substantial proportion of the overall
OA population, and given their relative young age when diagnosed with
OA, represent a considerable challenge with regard to management of
the OA. There is a lack of evidence to support a protective role of repair
or reconstructive surgery of the anterior cruciate ligament or meniscus
against future OA development. A consistent ﬁnding in a review of the
literature on the long-term consequences of these lesions is the often
poor reporting of critical study variables, precluding data pooling or a
meta-analysis.
Osteoarthritis development in the injured joints is caused by intra-articular
pathogenic processes initiated at the time of injury, combined with long-
term changes in dynamic joint loading. Variation in outcome is reinforced
by additional variables associated with the individual such as age, sex,
genetics, obesity, muscle strength, activity and re-injury. The joint with
a ligament lesion is thus inﬂuenced by the same risk factors associated
with other forms of OA. When we in addition consider the fact that many
persons have ligament lesions in the absence a history of joint injury, it is
apparent that such lesions often are an integral part of OA development,
providing further evidence that OA is a disease of the joint, not only of
the cartilage. Further, there is little reason for the continued use of the
terms primary and secondary OA.
A better understanding of the variables that inﬂuence the risk of OA
development in the presence of ligament lesions will improve future
prevention and treatment strategies. In evaluating medical treatment we
now expect large randomized clinical trials (RCT) complemented by post-
marketing monitoring. In instances where an RCT is not feasible, natural
history and other observational cohort studies need to be as carefully
designed and reported as the classical RCT.
I-17 PREVENTION OF OA IN THE YOUNG: THE ROLE OF
INJURIES, TRAINING AND MUSCLES
E.M. Roos. University of Southern Denmark, Odense, DENMARK
Purpose: Knee injury and muscle weakness are separate and modiﬁable
risk factors of knee OA that are suitable for intervention strategies. Muscle
weakness is frequently seen following knee injury and the individual
importance of these two intertwined factors in development of knee OA
after injury has not been assessed.
Anterior cruciate ligament (ACL) injury and meniscal injury are associated
with the development of osteoarthritis (OA) in the long-term, leading to
pain, functional limitations and decline in quality of life in the young or
middle-aged adult. There is no evidence to suggest that surgical inter-
ventions, such as reconstruction of the ACL, meniscectomy or meniscal
repair, prevents or reduces the rate of early-onset OA. On the contrary,
the prevalence of OA may even be higher in surgically treated patients.
Despite these long-term consequences, surgical treatment is widely used
following knee injury. Some recent studies indicate exercise being at least
as effective as surgery in reducing pain and improving function following
knee injury.
An increasing number of injury prevention programs targeted at reducing
the risk of knee injury in general and ACL injury in particular have
been reported in the literature. Although a number of risk factors for
ACL injury have been suggested, only the biomechanical risk factors
have been examined sufﬁciently to support the design and evaluation
of prevention interventions. Most prevention programs attempt to alter
dynamic loading of the tibiofemoral joint through neuromuscular and
proprioceptive training. Successful programs share a number of common
elements. Most include one or more of the following: traditional stretching,
strengthening, awareness of high risk positions, technique modiﬁcation,
aerobic conditioning, sports speciﬁc agilities, proprioceptive and balance
training and plyometrics. The importance of a neutral dynamic alignment
of the lower extremity; i.e. a straight line though the hip, knee and
foot, is emphasized. The studies to date focusing on biomechanical
modiﬁcations have resulted in the reduction of lower extremity injuries
in athletes. However, the studies vary widely both in their approach to
injury prevention and the validity of the study design. Most studies to date
have been non-randomized and few have been conducted as randomized,
controlled trials.
In summary, training according to neuromuscular principles to improve
dynamic alignment is successfully used to prevent knee injury and re-
habilitate following knee injury. It remains to be shown if neuromuscular
training may also prevent development of knee OA.
I-18 SHIFT FROM ALK5 TO ALK1 RECEPTOR USAGE
P.M. van der Kraan. Radboud University, Medical Centre, Nijmegen,
NETHERLANDS
Purpose: Osteoarthritis (OA), the most common form of arthritis, is
characterized by focal lesions of the articular cartilage, synovial ﬁbro-
sis, and new bone formation (osteophytes) at the joint margins. OA-
mediated cartilage damage is regarded as the result of a predominantly
chondrocyte-controlled degradation process, caused by a misbalance
between anabolic and catabolic processes. Aberrant chondrocyte differ-
entiation, leading to increased metalloprotease expression, is thought to
be at the root of OA development.
Methods: Since members of the TGF beta superfamily play important
roles in the regulation of chondrocyte differentiation, we have studied
TGF beta and BMP signaling during ageing, the major risk factor for OA,
and OA development.
Results: We were able to demonstrate that TGF beta is highly involved
in all aspects of OA development and progression. Not only we could
show that TGF beta is an essential player in the induction of osteophytes
and synovial ﬁbrosis, but also alteration in TGF beta signaling appeared
to be at the root of the most important hallmark of OA, cartilage loss.
We have strong clues that changes in chondrocyte TGF beta signaling
during ageing results in OA development. We have found that during
ageing and in experimental models a shift in type I TGF beta receptors
occurs, from ALK5 to ALK1 signaling. Moreover, in human OA cartilage a
strong correlation between ALK1 and MMP13 expression was observed.
Conclusions: Changes in TGF beta signaling play an essential role
in cartilage degradation. It can be concluded that TGF beta plays an
essential role in cartilage breakdown, osteophyte formation and synovial
ﬁbrosis in OA. Modiﬁcation of TGF beta signaling could be an attractive
target for OA therapy.
I-19 THE ROLE OF VASCULAR ENDOTHELIAL GROWTH
FACTORS AND OXYGEN METABOLITES IN CARTILAGE:
CHONDROCYTE AGEING IN OSTEOARTHRITIS
K. Yudoh, R. Karasawa, K. Masuko, T. Kato, K. Nishioka. St. Marianna
University School of Medicine, Kawasaki City, JAPAN
Purpose: Recently, attention has been drawn to the roles of oxidative
stress and related cartilage/chondrocyte aging in the pathogenesis of os-
teoarthritis (OA). Numerous reports have already revealed that oxidative
stress could inﬂuence chondrocyte activity and the cellular aging during
the progression of OA. Recent studies in human articular chondrocytes
from patients with OA clearly showed that features of chondrocyte senes-
cence occur in vivo, suggesting that the age-related changes in articular
cartilage increase vulnerability of the tissue to degeneration, and the
association between cartilage degeneration and aging is due, at least
in part, to features of chondrocyte senescence.
Cellular senescence is classiﬁed into 2 types, intrinsic senes-
cence (replicative senescence) and extrinsic senescence (telomere-
independent senescence). It is well known that extrinsic senescence
is induced by several kinds of stresses such as oxidative stress and
inﬂammation. A variety of catabolic stresses may induce the extrinsic
stress-induced senescence of articular chondrocytes. Among the extrinsic
stresses, oxidative stress may directly induce the down-regulation of
chondrocyte activity and the cellular senescence. We comﬁrmed the
involvement of oxidative stress in the pathogenesis of OA from the point
of view of chondrocyte aging.
Methods: We examined that effects of oxidative stress and angiogenic
growth factors on the catabolic stress-induced production of matrix de-
grading enzymes and the down-regulated production of matrix proteins,
cellular senescence and apoptosis in chondrocytes in vitro. Also, to
develop the novel therapeutic agent, the inhibitory effect of antioxidant,
newly developed nanocarbon molecule C60, on cartilage degeneration
was studied in the OA rabbit model produced by resection of the joint
ligament.
Results: We demonstrate the regulatory mechanism of chondrocyte
senescence that may be induced by stressful factors such as oxida-
tive stress and inﬂammation. We have focused on the implication of
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stress-induced over-expression of caveolin-1 in the cellular aging. Our
recent study revealed that angiogenic growth factors, especially vascular
endothelial growth factor (VEGF), downregulate catabolic activity and
cellular aging, and also maintain anabolic viability in chondrocytes. We
also review the underlying signal transduction pathways. Finally, we show
that newly developed antioxidant C60 is a useful as a therapuetic agent
sto reduce articular cartilage degeneration in the OA rabbit model.
Conclusions: Our studies reported here sought to demonstrate in the
OA model in vitro and in vivo that oxidative stress is closely involved in
the caritilage/chondrocyte aging and degeneration and that angiogenic
growth factors may at least in part participate in the pathogenesis of OA.
Also, we demenstrate that water-soluble C60 fullerene, a strong free-
radical scavenger, can function as a protective agent against the catabolic
stress-induced degeneration of articular cartilage.
I-20 THE APPLICATION OF PROTEOMICS IN THE STUDY OF
OSTEOARTHRITIS
D.S. Gibson. Queen’s University Belfast, Belfast, UNITED KINGDOM
Purpose: For a highly complex, multifaceted disorder such as osteoarthri-
tis, proteomic approaches have much to offer. Biomarker “ﬁngerprints”
which indicate disease outcome, networks of molecular pathology and
therapeutic targets can be ﬁltered out from background signals with
proteomic techniques.
Methods: Following closely on the heels of genomic screening, proteomic
platforms have the potential to provide additional levels of understanding
to the leading edge of osteoarthritic disease. Proteomic tools have the
signiﬁcant advantage in not precluding biomarker identity, so research
strategies can be formed in an objective, “unsupervised” fashion.
Results: This talk aims to give the unitiated an overview of the tech-
nologies currently available, highlighting their assets and pitfalls. A brief
history of ﬁndings to date from published proteomics studies of synovial
ﬂuid, cells and tissue will be reviewed from a variety of arthrides. The
importance of formulating clinically relevant questions will form a major
focus and novel strategies and sufﬁcient powering of studies will be
discussed.
Conclusions: This workshop gives the opportunity to learn of the skills
now available, giving inspiration and expanding on existing knowledge.
The content is pitched at scientists and clinicians with limited knowledge
of global proteomic technologies and strategies and an interest in apply-
ing them in the study of osteoarthritis.
I-21 COMBINED TRANSCRIPTOME AND PROTEOME
APPROACHES TO ELUCIDATE GENE EXPRESSION
PATTERNS OF SYNOVIAL TISSUES AND SYNOVIAL FLUIDS
FROM PATIENTS WITH RHEUMATOID ARTHRITIS VERSUS
OSTEOARTHRITIS
M.O. Glocker. Proteome Center Rostock, Institute of Immunology,
University of Rostock, Rostock, GERMANY
Purpose:With the availability of the human genome sequence and those
of animal models, data driven research for unravelling the molecular
grounds of Rheumatoid Arthritis (RA) and Osteoarthritis, respectively, can
be considered a realistic challenge to the scientiﬁc community.
Methods: A comprehensive research strategy is presented for studying
multifactorial polygenic (autoimmune) diseases, enabling the integration
of multiple research efforts by so called proteomics and systems biology
approaches. An integrative scientiﬁc concept is discussed of how to
elucidate molecular mechanisms of complex diseases using state-of-the-
art methodologies in functional and comparative genomics.
Results: RNA, protein, and peptide microarray proﬁles are currently
obtained in cutting edge research projects producing gene signature
read-outs rather than single DNA and/or protein markers. A continuous
interchange of data-driven and hypothesis-driven research has been
established in order to investigate the value of such “marker signatures”.
Conclusions: Currently, a comprehensive study of the RNA and pro-
tein regimes is undertaken that eventually will lead to a “holistic” view
of signalling pathways that are expected to reveal how the respective
molecules and the cells themselves interact with each other; hopefully
leading to new diagnostics and therapeutics in the future.
I-22 RHO SIGNALING PATHWAYS IN CARTILAGE DEVELOPMENT
AND OSTEOARTHRITIS
F. Beier. University of Western Ontario, London, ON, CANADA
Purpose: To compare the role of Rho GTPases in the control of the
chondrocyte phenotype in development and osteoarthritis.
Methods: Rho GTPase activity in chondrocytes was determined by
G-LISA assay. Activities of speciﬁc Rho GTPases in chondrocytes were
manipulated using pharmacological and genetic approaches. Effects of
these manipulations on chondrocyte physiology in monolayer culture,
organ culture and mice were investigated using a variety of techniques, in-
cluding real-time PCR, histological and immunohistochemical techniques,
cytoskeletal staining and proliferation assays.
Results: Our results show that RhoA through its mediators ROCK1/2
suppresses both early and late (hypertrophic) chondrocyte differentiation
during cartilage development. Similarly, Rho/ROCK mediates loss of
the chondrocyte phenotype in response to transforming growth factor
alpha (TGFalpha), a growth factor that we have shown to be upregu-
lated in osteoarthritic cartilage. Importantly, ROCK inhibition suppresses
TGFalpha-induced breakdown of collagen II and aggrecan in articular
cartilage explants. In contrast, other Rho family members, most notably
Rac1 and Cdc42, promote chondrocyte maturation at multiple stages
and through different mechanisms. Cartilage-speciﬁc deletion of the Rac1
gene in mice leads to severe chondrodysplasia, with reduced chondrocyte
proliferation, skeletal malformations (e.g. scoliosis and kyphosis) and
profound dwarﬁsm. These effects appear to be mediated, at least in part,
by altered iNOs expression and nitric oxide levels, showing a novel link
between Rho GTPase and nitroc oxide signaling.
Conclusions: Our data suggest that Rho GTPases play multiple and
speciﬁc roles in the control of both growth plate and articular chondrocyte
physiology. They may therefore present novel targets for therapeutic
interventions both for osteoarthritis and disorders of skeletal development,
such as chondrodysplasias.
I-23 EPIDEMIOLOGIC EVIDENCE FOR JOINT SHAPE AS A
CAUSE OF OA
N. Lane. University of California of Davis, Center for Healthy Aging,
Sacramento, CA, USA
Purpose: Osteoarthritis of the hip is a common cause of pain and
disability in older individuals. While the major risk factors for hip OA
are both genetic and environmental, minor variations in the proximal
femur or acetabular geometry have also been identiﬁed as potential risk
factors for hip OA. These observations support the hypothesis that subtle
variation in proximal femur/acetabular morphology may compromise the
joint biomechanically and lead to hip OA. Two recent studies will be
reviewed that utilized active shape modeling of the proximal femur to
determine what proximal femur shapes are risk factors for hip OA.
Methods: The pelvic radiographs used for these analyses were obtained
in the supine position. A baseline and follow-up radiograph was assessed
for presence and severity of radiographic hip OA with either a modiﬁed
Croft or a Kellgren and Lawrence method. The shape of the proximal
right femur was outlined using a digitized radiograph from the baseline
visit, by placing points evenly spaced points around the proximal femur.
The Active Shape Modeling Program (University of Manchester, UK) was
applied to the datasets to assess shapes in the femoral head, neck and
shaft before, during and after the development of radiographic hip OA.
Scores of shape variance, or mode scores were assigned to 10 modes of
variation in each hip, and differences in mode scores were determined.
Results: Incident hip OA study: the baseline shape analysis was sig-
niﬁcantly different between RHOA cases and controls in 3 modes (3,
5, and 9) (p< 0.001). Mode 3 (associated with the most variance of
9%) represented a subgroup with incident RHOA characterized by a
larger femoral head. Each of those three modes predicted incident RHOA
with adjusted ORs of around 1.7. A separate study reported signiﬁcant
differences in the femoral head shape between OA cases and controls
and hips with OA progression but not in the control group over time.
Conclusions: These studies and others support the hypothesis that
subtle variations in the shape of the proximal femur (either the femoral
head or femoral neck) and or the acetabulum appear to increase the risk
of incident and progressive RHOA. Research should now be directed
toward novel interventions that might be able slow the progression of hip
OA in individuals with these subtle variations in hip shape.
